Dermatitis

Papers
(The median citation count of Dermatitis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Long-Term Narrowband UV-B Efficacy in Moderate to Severe Atopic Dermatitis172
Environmental Dermatitis115
Association of Adult Atopic Dermatitis Severity with Bacterial, Viral, and Fungal Skin Infections42
Koebnerization from Insulin Pump and Continuous Glucose Monitor in a Patient with Psoriasis27
Systemic Treatment of Cutaneous Adverse Events after Immune Checkpoint Inhibitor Therapy: A Review21
Letter: Neonatal BCG Vaccination for Eczema Prevention18
Solvent Orange 60 in Tortoiseshell Spectacle Frames: The Importance of Patch Testing to This Rare Allergen18
Compositional and Functional Profile of Gut Microbiota in a Cohort of Adult Spanish Patients with Atopic Dermatitis Using Metagenomics: A Cross-Sectional Study18
Occupational Contact Dermatitis in Food Handlers: A 26-Year Retrospective Multicentre Study in North-East Italy (Triveneto Group on Research on Contact Dermatitis)16
Recalcitrant Dyshidrotic Eczema Successfully Treated with Upadacitinib15
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® from the Patient's Perspective: A Systematic Review15
Correspondence on “Efficacy, Safety, and Early Relapse after Cessation of Upadacitinib Versus Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis: A Real-World Study in China”15
Day 2 Patch Testing Does Not Impact Final Diagnosis in Patch Testing Process15
Letter: Lebrikizumab for Refractory Atopic Dermatitis14
Improved Investigator Global Assessment, Allergic Contact Dermatitis-11, Dermatology Life Quality Index, and Global Quality of Life and Severity Scores after Patch Testing in Dermatitis Patients14
Letter: A Case Series Demonstrating Co-Reactivity of a Cocamidopropyl Hydroxysultaine-Containing Facial Cleanser with Dimethylamines and Amidoamine14
A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity14
Revisiting Contact Sensitization Among Patients With LPP/FFA: Cross-Sectional Findings From 55 Cases14
Toward Probabilistic-Based (Naranjo-Like) Allergic Contact Dermatitis Algorithm13
Letter: Allergic Contact Dermatitis to Topical Minoxidil: Report of Two Cases12
Potential Allergens in Wound Care Products12
Correction to: Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis, by Stein Gold et al. Dermatitis 12
Precious Contactants: A Case of Professional Allergic Contact Dermatitis in a Jeweler12
Systematic Review of Systemic Corticosteroid Effects on Patch Testing11
Joint Pain and Inflammatory Arthropathy after Dupilumab Use in Atopic Dermatitis: A Systematic Review and Meta-Analysis11
Thrombocytopenia after Dupilumab for the Treatment of Atopic Dermatitis11
Atopic Dermatitis in Latin America: A Roadmap to Address Data Collection, Knowledge Gaps, and Challenges11
Persistent Dermatitis® in an Infant11
Effectiveness of Tralokinumab for Different Anatomical Sites and Clinical Signs in Atopic Dermatitis: A 36-Week Real-World Study11
Granuloma Inframammary Adultorum of Erosive Papulonodular Dermatosis11
Poppers Dermatitis®: A Systematic Review on a Unique Form of Contact Dermatitis® in the MSM Community11
From Protection to Problem: A Case of Allergic Contact Dermatitis to Rubber Accelerators in a Nail Technician Wearing Latex Gloves11
Are Patch Testing Reactions Underrecognized in Skin of Color? Evaluating the Frequency of Borderline Reactions by Fitzpatrick Skin Type11
Updates to the Research Institute for Fragrance Materials, Inc. Confirmation of No Induction in Human Test Standard Protocol10
An Open-Label Prospective Observational Study of Tralokinumab in Atopic Dermatitis Patients with Inadequate Response to Dupilumab10
Higher Prevalence of Contact Sensitization to Dodecyl Gallate in Patients With Atopic Dermatitis: A Cross-Sectional Study10
Panthenol Allergic Contact Dermatitis: Sources of Exposure, Reported Cases, and a Call for More Frequent Testing10
Exclusion of Disperse Orange 3 from the Textile Dye Mix Present in the Baseline Patch-Test Series: A Study by the International Contact Dermatitis Research Group10
Objective Assessment of Allergic Patch Test Reactions: Evaluation of a 3D Imaging System Versus Standard iPad Imaging for Patch Test Reactions10
Letter: The Impact of Allergen Avoidance in Burning Mouth Syndrome: A Case Series10
Letter: Patch Test in Children: One Size Does Not Fit Them All9
Letter: Clinical Characteristics of Intrinsic Versus Extrinsic Atopic Dermatitis in Chinese Patients9
Allergic Contact Dermatitis to Sorbitan Sesquioleate in Adaptic Nonadhering Dressing9
Barriers to Patch Testing: Assessing Reimbursement Challenges and Practice Patterns Among Members of the American Contact Dermatitis Society9
New Onset of Vitiligo and Atopic Dermatitis–Like Eczematous Dermatitis after Pfizer BioNTech's BNT162b2 Vaccination9
Letter: Description of Two Cases of Spider Bites Attributed to Loxosceles rufescens (Araneae, Sicariidae) in Albania9
Micellar Water Mayhem: A New Source of Biguanide-Related Allergic Contact Dermatitis9
The Frequency and Utility of Drug Cessation Trials in Older Adults with Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort Study9
Hair Dyes Sensitization and Cross-Reactions: Challenges and Solutions: A Systematic Review of Hair Dye Allergens' Prevalence8
Trends in Patch-Test Positivity to Methylchloroisothiazolinone and Methylisothiazolinone Based on Regulatory Status: A Systematic Review8
Is Patch Test Necessary in Children to Solve the Clinical Conundrum of Foot Eczema8
Trends in Patch Testing of Black Patients: The Mayo Clinic Decade Experience (January 1, 2011, to December 31, 2020)8
An Exceptional Case of Recall Phenomenon to Hypersensitivity to Amoxicillin8
Association of Adult Atopic Dermatitis Severity with Decreased Physical Activity: A Cross-sectional Study8
Patch Testing With Nickel Sulfate 5.0% Traces Significantly More Contact Allergy Than 2.5%: A Prospective Study Within the International Contact Dermatitis Research Group8
A Compositional Analysis of Preservative Systems in Cosmetics Intended for Infants8
Psychological Stress, Resilience, and Social Support in Patients With Allergic Contact Dermatitis8
Dermatitis Venenata: Then and Now8
Allergic Contact Dermatitis Mimicking Anti–Interleukin 17 Eczematous Eruption8
Reproducing Hand Dermatitis Morphology through Pantomime: A Clinical Pearl to Identify Allergic Contact Dermatitis to Shampoo8
ACDS 34th Annual Meeting Abstracts, Thursday, March 16, 2023, New Orleans8
Lanolin8
Trichoscopy Features of Allergic Contact Dermatitis of the Scalp: A Prospective Case Series8
Acknowledgment of Reviewers 20257
Letter: Allergic Contact Dermatitis to a Topical Postoperative Medication Mimicking Metal Sensitization7
When Relief Becomes a Reaction: Timolol-Linked Periorbital Dermatitis7
Cross-Reactivity between Propylene Glycol and Butylene Glycol7
User Feedback and Effects of Colloidal Oatmeal Coated Gloves Compared with Standard Nitrile Examination Gloves Among Health Care Workers7
Self-Assessment7
Self-Assessment7
Effectiveness of Janus Kinase Inhibitors for the Management of Atopic Dermatitis and Concomitant Occupational Allergic Contact Dermatitis: A Real-Life Study7
Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient7
Reactions to Pramoxine, Our Experience from 2020 to 20237
Allergic Contact Dermatitis from Brimonidine Tartrate Eye Drops: A Rare Dermatological Reaction with a “Teardrop Streak Sign”7
Clarification and Modification of the International Contact Dermatitis Research Group Classification of Patch Test Reactions on Behalf of the International Contact Dermatitis Research Group7
Self-Assessment7
A Case of Morphea after COVID-19 Vaccination7
Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis7
Letter: When Hair Straightening Turns Harmful: Acute Toxic Contact Dermatitis Induced by Straight Hair Treatment6
Initial Consensus for the Management of Topical Steroid Withdrawal: A Delphi Study6
Allergic Contact Dermatitis from 100% Mineral Oil Supported by Repeated Open Application Test6
Daily Patient’s Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study6
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores between Different Phenotypes of Atopic Dermatitis in Patients before and after Biologic Therapy with Dupilumab6
Vitiligo-Like Depigmentation Induced by Anti–Programmed Death 1 Antibody6
Apolipoprotein B as a Protective Factor Against Atopic Dermatitis: Insights Into Lipid Metabolism From a Large Prospective Cohort of 454,974 Individuals6
Allergic Contact Stomatitis Caused by (Meth)acrylates in a Gingival Protection Product Used during Teeth Whitening6
Failure of Dupilimab with Severe Prurigo Nodularis That Responded Well to Abrocitinib6
Investigation of Commercial Essential Oils for Formaldehyde Content6
Letter: Systemic Contact Dermatitis Caused by Metal Stent Successfully Treated With Dupilumab6
Phenobarbital-Induced Pellagra: A Diagnosis Not to Overlook6
Increasing Diversity, Equity, and Inclusion in Dermatitis Research: A Dermatitis Journal Call for Action6
Granular Parakeratosis Induced by Benzalkonium Chloride Masquerading as Allergic Contact Dermatitis after Circumcision6
The Diagnostic Value of Delayed-Type Reactions to Perennial Aeroallergens for Atopic Disease6
Analysis of Contact Allergens in Polyvinyl Chloride Examination Gloves in the United States6
Janus Kinase Inhibitors’ Effect on Patch Testing: A Systematic Review6
No Evidence of Causal Association between Atopic Dermatitis and Primary Open-Angle Glaucoma: A Bidirectional Two-Sample Mendelian Randomization Study6
Systemic Contact Dermatitis® to Cinnamon: A Case Report6
The Association between Atopic Dermatitis and Allergic Contact Dermatitis: A Cross-Sectional Analysis Using the All of Us Research Program6
Ocular Adverse Events in Patients with Atopic Dermatitis Treated with Upadacitinib: A Real-Life Experience5
Airborne Contact Dermatitis® Due to Budesonide by Multiple Proxies5
Toxin of the Year5
Contact Allergens in “PPD-Free” Hair Dyes5
Disproportionality Analysis of Nemolizumab in Patients with Atopic Dermatitis: A Real-World Pharmacovigilance Study5
A Review of Monographs in Contact Allergy: Systemic Drugs by Anton de Groot5
Contact Dermatitis in the United States: A Population-Based Study on Patient Visit Characteristics and Treatment Prescription Patterns5
Allergic Contact Cheilitis due to Candelilla Wax5
Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis5
Letter: Elevated Risk in Atopic Dermatitis Present in Patients with Hepatobiliary Dysfunction: A Retrospective Cohort Study on the TriNetX Database5
Decision-Making Factors for Systemic Therapies in Atopic Dermatitis: A Clinical Review5
Sensitization to Fragrance Markers from 1996 to 2016 in Northeastern Italy and Analysis of Occupational Relevance5
Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results5
The Eczema Area and Severity Index—A Practical Guide5
A Survey of Skin Reactions Associated with Acrylic Nail Cosmetics, with a Focus on Home Kits: Is There a Need for Regulation?5
Higher Occurrence of Ocular Surface Disease Symptoms in Patients with Atopic Dermatitis: Data from 57,464 Subjects in the FOREVER Cohort5
Impact of Atopic Dermatitis® on Quality of Life of Caregivers: A Systematic Review and Meta-Analysis5
Development of Granulomatous Allergic Contact Dermatitis to Hantavirus DNA Gold Particle Vaccine 14 Years after Administration4
Germline Mosaicism in STAT3 : A Pitfall for Genetic Diagnosis, Counseling, and Therapy of Hyper-IgE Syndrome4
Changes in Product Use and Quality of Life after Patch Testing in Children with Allergic Contact Dermatitis4
Low Prevalence of Fragrance Contact Allergy among Turkish Population4
Emerging Allergens in Eyelash and Eyebrow Cosmetics4
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis4
Work Productivity Loss and Health-Related Quality of Life in People Living with Atopic Dermatitis: A Canada-Wide Cross-Sectional Study4
Erythema Multiforme Secondary to Poison Ivy Contact Dermatitis4
Potential Allergens in Wound Care Products4
Safe Alloys for Patients with Common Metal Allergies4
Neonatal Filaggrin Genetic Screening and Counseling to Prevent Atopic Dermatitis in High-Risk Infants4
Demonstration of Convolutional Neural Networks to Determine Patch Test Reactivity4
Racial and Economic Differences in Inpatient Pediatric Atopic Dermatitis: An Analysis of the US Kids' Inpatient Database4
Bromide-Induced Acneiform Eruption4
Contact Allergy to Clotrimazole in a Patient With Stasis Dermatitis4
Letter: Short-Term Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis in Real-World Clinical Practice4
Recurrent Varicella after SARS-CoV-2 Vaccination in a Healthy Female4
A Patient-Reported Historical Disease Course and Flare Frequency in Adults With Moderate-to-Severe Atopic Dermatitis—A Pilot Study4
Chronic Eczema on Arms due to Aluminum Vaccine Resolved with Dupilumab4
Patient-Centered Communication Tools for the Patch Test Clinic4
Nonmedical Adhesive Allergens: Retrospective Analysis of Cross-Sectional Data from the North American Contact Dermatitis® Group, 2001–20184
Arteriovenous Malformation Mimicking Dermatitis® in the Lower Limb4
Contact Allergy to Cannabis and Related Essential Oils4
Para-Phenylenediamine-Induced Lichenoid Eruption With Involvement of the Oral Mucosa and Subsequent Contact Leukoderma4
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study4
Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994–2018)4
Eosinophilic Dermatitis due to Triptorelin Pamoate in a Patient with Prostate Cancer Confirmed by Patch Testing4
Allergic Contact Dermatitis to VenaSeal: A Sticky Situation3
Early Dupilumab Response Predicts Pediatric Atopic Dermatitis Disease Relapse3
Patch Testing with Nickel, Cobalt, and Chromium in Patients with Suspected Allergic Contact Dermatitis3
“Effects of Allergen Avoidance in Patients with Frontal Fibrosing Alopecia: A Retrospective Cohort Analysis”3
Ethics of Managing Recalcitrant Eczematous Dermatitis in Adults3
Letter: Dermatologists Versus Skinfluencers on TikTok: Investigating the Categories, Allergenicity, and Cost of Recommended Skincare Products3
Trips through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens3
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis3
No Causal Association between Genetic Markers of Smoking Behaviors and Genetic Markers of Atopic Dermatitis®: Evidence from a Mendelian Randomization Study3
Letter: Demographics of Positive Patch Test Reactions to Propylene Glycol3
Letter: Generalized Lichen Pigmentosus Triggered by Orthopedic Osteosynthesis Material3
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective Study3
The Patent Blue V Paradox: Hidden Offender, Serial Culprit3
Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies3
Characterization of Pediatric Patch Testing: A Retrospective Review, 2020–20233
A Cross-Sectional Analysis of Contact Allergens in Best-Selling Depilatory Products3
Letter: Upadacitinib-Induced Amenorrhea: A Rare Adverse Effect in Atopic Dermatitis Treatment3
Herbal Medicine in Children and Adults with Atopic Dermatitis: A Systematic Review and Meta-Analysis3
Concurrence of Eosinophilic Esophagitis and Dyshidrotic Eczema3
Self-Assessment3
Are We Reading Patch Test Reactions in a Uniform Way? An International Contact Dermatitis Research Group Study3
Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients3
Clearance of Periorificial Dermatitis with Tapinarof3
Allergic Contact Dermatitis Induced by Acrylate Exposure from a Vape Pen3
Acrylates Induced Oral Lichenoid Lesions with Generalized Lichen Planus Pigmentosus3
Severe Localized Vitiligo following Phototoxicity to Hydrochlorothiazide3
Effectiveness of a Skin Care Program with a Cream Containing Ceramide C and a Personalized Training for Secondary Prevention of Hand Contact Dermatitis3
Going Green and Adhesive-Free: Snap-in Reusable Menstrual Pads for Tampon and Pad Intolerance3
SELF-ASSESSMENT3
Letter: A Striking Case of Pseudo-Psoriatic Nail Changes Secondary to Acrylate Contact Allergy3
Acrylate Allergy from Mini Toys—The “Slime” of 2024?3
Contact Allergy to Propolis: Update 2013–20253
Economic Costs and Implications of Occupational Skin Disease, 2011–20203
North American Contact Dermatitis Group Patch Test Results: 2021–20223
Efficacy and Safety of Tralokinumab in Real Life: Possible Predictive Rapid Response Factors3
First Case of Superficial Epidermolytic Ichthyosis Successfully Treated by Dupilumab3
Characteristics of Litigations Involving Contact Dermatitis: An Exploratory Analysis3
The Toxin of the Year: Airborne PM 2.53
Self-Assessment3
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study3
Systemic Contact Dermatitis to Honey Detected by Propolis Patch Testing3
Formaldehyde Release From Eyelash Glues: Analysis Using the Chromotropic Acid Method3
Letter: Response to the Article Entitled “When Hair Straightening Turns Harmful: Acute Toxic Contact Dermatitis Induced by Straight Hair Treatment”3
Which Clinical Measurement Tools for Atopic Dermatitis Severity Make the Most Sense in Clinical Practice?3
Diagnosing Allergic Contact Dermatitis Using Deep Learning: Single-Arm, Pragmatic Clinical Trial with an Observer Performance Study to Compare Artificial Intelligence Performance with Human Reader Per3
Acute Localized Exanthematous Pustulosis Induced by a Spider Bite3
Patient-Reported Association between COVID-19 Infection or Vaccination and Onset of Allergic Contact Dermatitis®3
Cemiplimab-Induced Erythema Multiforme in a Patient with Metastatic Squamous Cell Carcinoma of the Penis3
Patch Test Results among Older Adults: A Retrospective Analysis of the North American Contact Dermatitis® Group Data (2009–2020)3
Allergic Contact Dermatitis®: A Bibliometric Analysis3
Exploring the Relationship between Dermatology Life Quality Index, Eczema Area and Severity Index, and Sleep Numerical Rating Scale and Pruritus Numerical Rating Scale in Patients with Atopic Dermatit2
Letter: Biological Therapies for Prurigo Nodularis in Systemic Disease2
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results from a Patient Survey2
Natural but Not Harmless: A Case of Pustular Allergic Contact Dermatitis Triggered by Propolis-Enriched Honey2
Evaluating Copositivity Patterns in Fragrance/Botanical Patch Testing through Hierarchical Clustering and Network Analysis2
Generalized Bullous Fixed Drug Eruption2
Allergic and Irritant Contact Dermatitis in Patients with Central or Peripheral Lines: A Scoping Review2
A “Nonallergen” Strikes Back: Allergic Contact Dermatitis to Parabens in Triamcinolone Ointment2
Prospective Randomized Double-Blind Vehicle-Controlled Study of Topical Coconut and Sunflower Seed Oil-Derived Isosorbide Diesters on Atopic Dermatitis2
Contact Sensitization in the Cleaning Industry: Updated Analysis of Contact Allergy Surveillance Data of the Information Network of Departments of Dermatology2
Dermatitis 2023: Where Are We Today?2
Letter: Dermographism and Follicular Traction Urticaria: Both Can Coexist2
Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 20212
Contact Allergens in Over-the-Counter Topical Antihistamine and Mast Cell Stabilizer Ophthalmic Agents2
Occupational Contact Dermatitis in Construction Workers: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001–20202
Zinc Supplementation for Epidermal Growth Factor Receptor Inhibitor–Related Periocular Dermatitis2
ACDS 36 th Annual Meeting Orlando, Florida March 6, 20252
Self-Assessment2
The Risk of Herpes Virus Infection in Patients with Atopic Dermatitis during Biologic Therapy: A Retrospective Records Based Observational Study2
Letter: Lip Sunscreens: Analysis of Allergenicity and Marketing Claims2
Self-Assessment2
Scratch Patch Testing to Dermabond in a Patient with Suspected Allergic Contact Dermatitis2
Tofacitinib, a JAK1/3 Inhibitor as Treatment for Linear IgA Bullous Dermatosis: A Case Report2
Letter: Reduced Staphylococcus aureus Burden on the Skin of Patients With Moderate-to-Severe Chronic Hand Dermatitis Treated W2
Pathogenic Colonization: Defining the Role of Staphylococcus aureus in Atopic Dermatitis2
New Sunscreens on the Block: An Evaluation of the Online Sunscreen Market in the United States2
Letter: Post-Marketing Efficacy of Nemolizumab for Prurigo Nodularis: A Single-Center Study with a Small Sample Size2
Not All Itch Is Created Equal in Atopic Dermatitis: A Prospective Observational Study of the Heterogeneous Characteristics of Itch2
Letter: Propranolol-Induced Acute Generalized Exanthematous Pustulosis Confirmed by Patch Testing: A Case Report2
Letter: Pediatric Allergic Contact Cheilitis Highlighting Unusual Exposures in a Polysensitized Child2
Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series2
Allergic Contact Dermatitis to Tea Tree Oil with No Sensitization to Fragrance Markers2
DRESS to Isoniazid in Pregnancy With a Short Latency Period: A Multidisciplinary Approach and Acutely Performed Patch Tests2
Patch Testing with Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013–20202
Self-Assessment2
Patch Test Reactivity to the Constituents of Thiuram Mix and Paraben Mix2
Topical Ectoin versus Topical Dexpanthenol for Managing Acute Radiodermatitis Associated with Breast Cancer Radiotherapy: A Randomized Double-Blind Study2
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up2
Prospective Cohort Study: Hexyl-2,5-Diaminobenzoate Is a Hypoallergenic Alternative for Patients With Allergic Contact Dermatitis to Para-Phenylenediamine2
Artificial Intelligence in Contact Dermatitis: Current and Future Perspectives2
SELF-ASSESSMENT2
Compositional Differences Between Brazilian and Chinese Propolis2
Disease Burden of Occupational Contact Dermatitis and Its Impact on Workforce Outcomes Among Health Care Workers: A Statewide Cross-Sectional Survey2
Occupational Seborrheic Dermatitis in a Steel Worker2
Increasing Use of Dupilumab and Decreasing Use of Patch Testing in Medicare Patients from 2017 to 2022: A Claims Database Study2
Immediate Hypersensitivity Reaction in a Worker Handling Morphine: A Case Report2
Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Obse2
Allergic Contact Dermatitis Obscured by Secondary Changes in Setting of Stimulant Use2
Letter: Transition of Hematological Indexes in 36-Week Treatment with Lebrikizumab for Atopic Dermatitis: A Real-World Prospective Japanese Study2
Sulfites: Allergen of the Year 20242
Letter: Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World Experience2
Dupilumab for Chronic Hand Eczema: A Systematic Review and Meta-Analysis2
The Association between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study2
Successful Treatment of Atopic Hand and Foot Eczema with Oral Janus Kinase 1 Inhibition2
Self-Assessment2
Irritancy Potential of Supergoop! ® Unseen Sunscreen: Recommendations for Patch Testing to This Popular Product2
The Prevalence of Type IV Hypersensitivity in Patients with Lichen Planopilaris and Frontal Fibrosing Alopecia2
Call for Papers: Special Issue on Skin of Color and DEI Initiatives2
0.085837125778198